Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001720234 | SCV000526432 | benign | not provided | 2021-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000537566 | SCV000656731 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002318452 | SCV000851377 | likely benign | Inborn genetic diseases | 2016-12-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000437458 | SCV001880053 | benign | not specified | 2020-12-22 | criteria provided, single submitter | clinical testing |